Dr. Alison R. Walker
Claim this profileMoffitt Cancer Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Myeloid Leukemia
5 reported clinical trials
8 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
CD22 positive
Philadelphia chromosome/BCR-ABL1 negative
2Acute Myeloid Leukemia
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Alison R. Walker is currently running
Venetoclax + CLAG-M
for AML
This multicenter, open-label phase II study combines CLAG-based therapy with or without venetoclax in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) in order to improve measurable residual disease (MRD) clearance and event-free survival. Investigators hypothesize that the addition of venetoclax to CLAG-M in patients with relapsed or refractory AML is safe, and superior to CLAG-M alone in improving patient outcomes.
Recruiting1 award Phase 26 criteria
Inotuzumab + Blinatumomab
for Acute Lymphoblastic Leukemia
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back, or does not respond to treatment. Immunotherapy with monoclonal antibodies, such as inotuzumab ozogamicin and blinatumomab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 210 criteria
More about Alison R. Walker
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Alison R. Walker has experience with
- Decitabine
- Venetoclax
- Bortezomib
- Sorafenib Tosylate
- Blinatumomab
- Inotuzumab Ozogamicin
Breakdown of trials Alison R. Walker has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Myeloid Leukemia
Myeloid Leukemia
Acute Lymphoblastic Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alison R. Walker specialize in?
Alison R. Walker focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved CD22 positive patients, or patients who are Philadelphia chromosome/BCR-ABL1 negative.
Is Alison R. Walker currently recruiting for clinical trials?
Yes, Alison R. Walker is currently recruiting for 3 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Alison R. Walker has studied deeply?
Yes, Alison R. Walker has studied treatments such as Decitabine, Venetoclax, Bortezomib.
What is the best way to schedule an appointment with Alison R. Walker?
Apply for one of the trials that Alison R. Walker is conducting.
What is the office address of Alison R. Walker?
The office of Alison R. Walker is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.